
0:00
28:32
Dr. Sam Sanders, internist at Bellevue Hospital in NYC, takes us through a case-based review of metabolic dysfunction–associated steatotic liver disease (MASLD), an increasingly common condition. We cover updated terminology, risk stratification using FIB-4 scoring and FibroScans, indications for hepatology referral, and new management strategies to prevent fibrosis progression and cirrhosis.
Advertising Inquiries: https://redcircle.com/brands
D'autres épisodes de "Run the List"



Ne ratez aucun épisode de “Run the List” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.








